Dr. Katherine Louise Maietta, M.D. Pediatrics Medicare: Accepting Medicare Assignments Practice Location: 9608 S Roberts Rd, Hickory Hills, IL 60457 Phone: 708-233-5333 Fax: 708-233-5348 |
News Archive
With a recent two-year, $833,000 grant from the U.S. Department of Defense, kinesiology professor Richard van Emmerik and colleagues at the University of Massachusetts Amherst hope to eventually help an estimated 1 million people worldwide living with progressive multiple sclerosis (MS) by creating an improved diagnostic test for this form of the disease, which is characterized by a steady decrease in nervous system function.
Mirth, LLC, a wholly owned subsidiary of Quality Systems, Inc. and a global leader in health information technology, announced today that Mirth® Connect version 3.0.1 is compliant with the ONC 2014 Edition criteria and was certified as an Electronic Health Record (EHR) Module on May 1, 2014 by the Certification Commission for Health Information Technology (CCHIT®), an ONC-ACB, in accordance with the applicable Eligible Providers (Ambulatory) certification criteria adopted by the Secretary of Health and Human Services.
University of South Florida neuroscientist R. Douglas Shytle's discovery of successful new clinical uses for mecamylamine, a drug once used to treat hypertension, has led to several issued patents on mecamylamine and related compounds. Earlier this month, Shytle, associate professor and research scientist at the USF Center of Excellence for Aging and Brain Repair and the USF Silver Child Development Center, received the university's 2009 "Excellence in Innovation" award.
Pancreatic cancer tumors addicted to mutant Kras signaling for their growth and progression have a ready-made substitute to tap if they're ever forced to go cold-turkey on the mutant oncogene, scientists at The University of Texas MD Anderson Cancer Center report in the journal Cell.
Boehringer Ingelheim today announced that new data evaluating volasertib, an investigational polo-like kinase (Plk) inhibitor, will be presented at the 54th American Society of Hematology (ASH) annual meeting taking place December 8-11 in Atlanta, Ga.
› Verified 4 days ago